Finally, the in vitro experiments showed that TPPU efficiently reduces the proliferation of human PA-SMC, which could be translated in the long term by a protective effect against the development of PAH in patients treated with sEH inhibitors. Here, EPHX2 is linked to pulmonary arterial hypertension.